NEW YORK (GenomeWeb) – Rainbow Genomics, a Hong Kong-based genetic testing company, said today that it plans to contract data analysis and clinical interpretation from the University of California, Los Angeles Clinical Genomics Center for its exome-sequencing tests.
Rainbow's exome sequencing tests cover cardiovascular diseases as well as both adult and pediatric genetic disorders. The firm noted that it also covers Asian-specific genes that are not often included in many panel-based gene tests.
Under the alliance, sequencing will be performed at Rainbow's CAP-accredited laboratory, while the UCLA Clinical Genomics Center will deliver clinical reports.
Daniel Siu, CEO of Rainbow Genomics, said in a statement that the relationship between Rainbow and UCLA will enable "many middle-class families to access exceptionally high-quality exome sequencing genetic tests that may finally provide a diagnosis."
Wayne Grody, director of molecular diagnostics at the UCLA Health System, added that Asian countries, despite their "robust economies and impressive technology," have "remained underserved in the areas of genetic testing and genomic medicine."